Lloyd P. Aiello, MD, PhD, has been named the 2020 recipient of the prestigious Friedenwald Award from the Association for Research in Vision and Ophthalmology (ARVO). The Friedenwald Award was...
Lloyd Paul Aiello, MD, PhD, Professor of Ophthalmology and Co-Director of the Diabetic Eye Disease Center of Excellence at Harvard Medical School, has been inducted into the Retina Hall of...
Nearly 40 Harvard Ophthalmology faculty and trainees from our affiliates—including Beetham Eye Institute at Joslin Diabetes Center, Boston Children's Hospital, Mass. Eye and Ear, and VA Boston...
Konstantina Sampani, MD, Clinical Research Fellow at The Beetham Eye Institute at Joslin Diabetes Center, received ARVO's 2019 Science Communications Training Fellowship. The one year program -...
Mohammad Dahrouj, MD, PhD, a second-year ophthalmology resident at Harvard Medical School, was selected to receive the 2017 Gragoudas-Folkman Award, which provides up to $20,000 to support residents...
Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.
Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in...
